» Articles » PMID: 32677073

Deep Model with Siamese Network for Viable and Necrotic Tumor Regions Assessment in Osteosarcoma

Overview
Journal Med Phys
Specialty Biophysics
Date 2020 Jul 18
PMID 32677073
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To achieve automatic classification of viable and necrotic tumor regions in osteosarcoma, most of the existing deep learning methods can only design a simple model to prevent overfitting on small datasets, which leads to the weak ability of extracting image features and low accuracy of the models. In order to solve the above problem, a deep model with Siamese network (DS-Net) was designed in this paper.

Methods: The DS-Net constructed on the basis of full convolutional networks is composed of an auxiliary supervision network (ASN) and a classification network. The construction of the ASN based on the Siamese network aims to solve the problem of a small training set (the main bottleneck of deep learning in medical images). It uses paired data as the input and updates the network through combined labels. The classification network uses the features extracted by the ASN to perform accurate classification.

Results: Pathological diagnosis is the most accurate method to identify osteosarcoma. However, due to intraclass variation and interclass similarity, it is challenging for pathologists to accurately identify osteosarcoma. Through the experiments on hematoxylin and eosin (H&E)-stained osteosarcoma histology slides, the DS-Net we constructed can achieve an average accuracy of 95.1%. Compared with existing methods, the DS-Net performs best in the test dataset.

Conclusions: The DS-Net we constructed can not only effectively realize the histological classification of osteosarcoma, but also be applicable to many other medical image classification tasks affected by small datasets.

Citing Articles

Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma.

Kawaguchi K, Miyama K, Endo M, Bise R, Kohashi K, Hirose T NPJ Precis Oncol. 2024; 8(1):16.

PMID: 38253709 PMC: 10803362. DOI: 10.1038/s41698-024-00515-y.


Adapted Deep Ensemble Learning-Based Voting Classifier for Osteosarcoma Cancer Classification.

Walid M, Mollick S, Shill P, Baowaly M, Islam M, Ahamad M Diagnostics (Basel). 2023; 13(19).

PMID: 37835898 PMC: 10572954. DOI: 10.3390/diagnostics13193155.


A Novel Hybrid Approach for Classifying Osteosarcoma Using Deep Feature Extraction and Multilayer Perceptron.

Aziz M, Mahmud S, Elahe M, Jahan H, Rahman M, Nandi D Diagnostics (Basel). 2023; 13(12).

PMID: 37371001 PMC: 10297313. DOI: 10.3390/diagnostics13122106.


Artificial Intelligence-Aided Diagnosis Solution by Enhancing the Edge Features of Medical Images.

Lv B, Liu F, Li Y, Nie J, Gou F, Wu J Diagnostics (Basel). 2023; 13(6).

PMID: 36980371 PMC: 10047640. DOI: 10.3390/diagnostics13061063.


Deep Learning-Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome Prediction.

Ho D, Agaram N, Jean M, Suser S, Chu C, Vanderbilt C Am J Pathol. 2022; 193(3):341-349.

PMID: 36563747 PMC: 10013034. DOI: 10.1016/j.ajpath.2022.12.004.